This inventor holds 3 USPTO granted patents. Top assignees: Elf Sanofi, K.u. Leuven Research & Development. Active years: 1995-1999.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1995-1999
Title: Michel Renard: Innovator in Chiral Catalysis
Introduction
Michel Renard is a notable inventor based in Brussels, Belgium. He has made significant contributions to the field of chemistry, particularly in the development of chiral solid catalysts. With a total of 3 patents to his name, Renard's work has implications in pharmaceutical applications.
Latest Patents
One of Renard's latest patents focuses on a chiral solid catalyst and its preparation for the production of indolizine derivatives with pharmaceutical activity. The invention relates to indolizine derivatives of a general formula where X denotes an --S or --SO₂-- group. This innovative approach has the potential to enhance the efficacy of pharmaceutical compounds.
Career Highlights
Throughout his career, Michel Renard has worked with prominent organizations such as Elf Sanofi and K.U. Leuven Research & Development. His experience in these companies has allowed him to refine his expertise in catalysis and pharmaceutical development.
Collaborations
Renard has collaborated with esteemed colleagues, including Jean Gubin and Willy Van Brussel. These partnerships have contributed to the advancement of his research and the successful development of his patents.
Conclusion
Michel Renard's contributions to the field of chiral catalysis and his innovative patents highlight his role as a significant figure in the scientific community. His work continues to influence pharmaceutical research and development.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile